Tuesday - July 15, 2025
New Buprenorphine for OUD Labels Clarify Higher Doses Appropriate for Some Patients
June 09, 2025
CHEVY CHASE, Maryland, June 9 [Category: Health Care] -- The American Society of Addiction Medicine posted the following news release:

* * *

New Buprenorphine for OUD Labels Clarify Higher Doses Appropriate for Some Patients

*

As of May 2025, Suboxone and Zubsolv, transmucosal buprenorphine products for the treatment of opioid use disorder (OUD), have modified their labels to clarify that there is no maximum daily dosage.

The labe . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products